Have you seen the Pharma in Focus 'Covid Vaccine Tracker'? Check it out here pharmainfocus.com.au #pharma #covid19 #pharmainfocus #pharmanews #vaccine

Great to see our journalism recognised on ABC’s Media Watch this week! abc.net.au/mediawatch/epi…

Does Australia have a Covid vaccine deal now? Not according to CSL, which says its 'agreement' is not legally binding with a contract expected "in the next four to six weeks". #ausgov jumps the gun again.

With only 34 new drugs registered in 2017, TGA Australia approvals fell below average but rates are looking to pick up in 2018 buff.ly/2D8Qyma

Several creditors owed some of the $4m in the Hammond & Thackeray collapse are concerned there has been no creditor meeting called by the current liquidator and wants it removed buff.ly/2DCFuyN

Aust pharma industry still sticks to traditional media but @MSD_Aus, AbbVie Australia and GSK Australia are part of those leading the pack when it comes to #twitter buff.ly/2GV86Vx

The FDA has issued a warning letter detailing 'significant violations' to a South Korean biosim facility which makes #Inflectra for the Aust market buff.ly/2EOrF13

A patient group has launched a national campaign to list two new breast cancer drugs from Novartis and Pfizer Inc. on the #PBS, pre-empting PBAC's third review of the pair buff.ly/2E8igA9

A GlobalData Healthcare report predicts MSD will lead the industry in R&D collaboration this year after a bumper 2017 for the pharma giant buff.ly/2nSaYKK

ACCC flexes new muscle: pharma not a direct target but not off the hook buff.ly/2EETd7W

Older sales channels dying but reps not getting digital right, says Sanofi Digital Medicines Head buff.ly/2oo2iex

New data laws could trap pharma, @ShelstonIP lawyers warn buff.ly/2ohSzHz

#PBAC clocks a record seven meetings on its 2018 calendar buff.ly/2FxAwo6

New @Shireplc drug granted speedy TGA Australia review tag, company says buff.ly/2GGY8pu

Pharma's top HCPs revealed: thousands sponsored but which #HCPs received the most? buff.ly/2Ferv2e

'Big picture' Medicines Australia council gains traction buff.ly/2CZauXR

MA CEO hunt almost over buff.ly/2rKOUD8

Figures show PBS stagnant in Q1 buff.ly/2rKOUD8

Aust pharma not much like world, according to revenue comparison buff.ly/2rKOUD8

CAR-Ts get patent bonus buff.ly/2rKOUD8